Jason G. Duncan

Chief Administrative Officer at NEUMORA THERAPEUTICS, INC.

52 year

Health Technology

Consumer Services

Consumer Durables

Profile

Mr. Jason G.
Duncan is a Chief Legal & Administrative Officer at Neumora Therapeutics, Inc. and a Software Engineer at American Panel Corp.
Mr. Duncan was previously employed as a General Counsel by Albireo Pharma, Inc., a General Counsel by Stallergenes Greer, Inc., a Vice President, Head-Compliance & Legal by Sobi, Inc., a Vice President, Head-Compliance & Legal by Swedish Orphan Biovitrum AB, and an Associate General Counsel by EMD Serono, Inc. He received his undergraduate degree from Dickinson College and a graduate degree from Suffolk University Law School.

Jason G. Duncan active positions

Companies	Position	Start
NEUMORA THERAPEUTICS, INC.	Chief Administrative Officer	11/12/2023
American Panel Corp. American Panel Corp. Electronics/AppliancesConsumer Durables Manufactures freezers, warehouses, and refrigeration systems	Chief Tech/Sci/R&D Officer	-

All active positions of Jason G. Duncan

Former positions of Jason G. Duncan

Companies	Position	End
Stallergenes Greer, Inc. Stallergenes Greer, Inc. Pharmaceuticals: MajorHealth Technology Specializes in development and commercialization of allergy immunotherapy products for use in the diagnosis and treatment of allergies	General Counsel	31/05/2018
Sobi, Inc. Sobi, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Swedish Orphan Biovitrum AB, Sobi, Inc. is a biopharmaceutical company that develops and provides therapies for people living with rare diseases. The company is based in Waltham, MA. The company focuses on key therapeutic areas including hematology, immunology, nephrology, and specialty care for hereditary metabolic and genetic diseases. Sobi offers a portfolio of medicines such as Alprolix®, Aspaveli®, Kineret®, Orfadin®, Tegsedi®, and others, addressing unmet medical needs in rare conditions.	Compliance Officer	30/09/2015
SWEDISH ORPHAN BIOVITRUM AB	Corporate Officer/Principal	31/07/2015
EMD Serono, Inc. EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines	Corporate Officer/Principal	30/06/2014
ALBIREO PHARMA, INC.	General Counsel	-

See the detail of Jason G. Duncan's experience

Training of Jason G. Duncan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jason G. Duncan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Dickinson College Dickinson College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
American Panel Corp. American Panel Corp. Electronics/AppliancesConsumer Durables Manufactures freezers, warehouses, and refrigeration systems	Consumer Durables
EMD Serono, Inc. EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines	Health Technology
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care	Health Technology
Suffolk University Law School Suffolk University Law School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Albireo Pharma, Inc. Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders	Health Technology
Stallergenes Greer, Inc. Stallergenes Greer, Inc. Pharmaceuticals: MajorHealth Technology Specializes in development and commercialization of allergy immunotherapy products for use in the diagnosis and treatment of allergies	Health Technology
Sobi, Inc. Sobi, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Swedish Orphan Biovitrum AB, Sobi, Inc. is a biopharmaceutical company that develops and provides therapies for people living with rare diseases. The company is based in Waltham, MA. The company focuses on key therapeutic areas including hematology, immunology, nephrology, and specialty care for hereditary metabolic and genetic diseases. Sobi offers a portfolio of medicines such as Alprolix®, Aspaveli®, Kineret®, Orfadin®, Tegsedi®, and others, addressing unmet medical needs in rare conditions.	Commercial Services
Neumora Therapeutics, Inc. Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases	Health Technology